Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
- PMID: 30449079
- PMCID: PMC6361021
- DOI: 10.5217/ir.2018.00096
Epidemiological trend in inflammatory bowel disease in Taiwan from 2001 to 2015: a nationwide populationbased study
Abstract
Background/aims: Incidences of inflammatory bowel diseases (IBDs), ulcerative colitis (UC), and Crohn's disease (CD), have been increasing in Asia. In this study, we report the relevant clinical characteristics and determined the epidemiological trend of IBD in Taiwan from 2001 to 2015.
Methods: A retrospective study was conducted to analyze data recorded from January 2001 through December 2015 in the registered database compiled by the National Health Insurance and provided by the Ministry of Health and Welfare, Taiwan.
Results: A total of 3,806 patients with catastrophic IBD illness were registered from 2001 to 2015 in Taiwan (CD, 919; UC, 2,887). The crude incidence of CD increased from 0.17/100,000 in 2001 to 0.47/100,000 in 2015, whereas that of UC increased from 0.54/100,000 in 2001 to 0.95/100,000 in 2015. The prevalence of CD increased from 0.6/100,000 in 2001 to 3.9/100,000 in 2015, whereas that of UC increased from 2.1/100,000 in 2001 to 12.8/100,000 in 2015. The male-to-female ratio in the study sample was 2.19 for CD and 1.62 for UC. The median age of those registered with CD was lower than that of those registered for UC: 38.86 and 44.86 years, respectively. A significantly greater increase in CD incidence rate was identified among 20 to 39-year-old compared with other age groups.
Conclusions: Using Taiwan's nationwide insurance database, we determined that the number of patients with CD increased more rapidly during the study period than the number of patients with UC, especially among age 20 to 39-year-old, resulting in a decreased UC-to-CD ratio.
Keywords: Colitis, ulcerative; Crohn disease; Incidence; Prevalence; Taiwan.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures







Similar articles
-
A nationwide population-based study of the inflammatory bowel diseases between 1998 and 2008 in Taiwan.BMC Gastroenterol. 2013 Dec 6;13:166. doi: 10.1186/1471-230X-13-166. BMC Gastroenterol. 2013. PMID: 24314308 Free PMC article.
-
Trends and risk factors of mortality analysis in patients with inflammatory bowel disease: a Taiwanese nationwide population-based study.J Transl Med. 2019 Dec 12;17(1):414. doi: 10.1186/s12967-019-02164-3. J Transl Med. 2019. PMID: 31831015 Free PMC article.
-
Temporal Trends of Inflammatory Bowel Diseases in Taiwan from 2016 to 2020: A Population-Based Study.Dig Dis Sci. 2024 Sep;69(9):3172-3179. doi: 10.1007/s10620-024-08518-2. Epub 2024 Jun 29. Dig Dis Sci. 2024. PMID: 38949750
-
Epidemiology of inflammatory bowel disease in South America: A systematic review.World J Gastroenterol. 2019 Dec 21;25(47):6866-6875. doi: 10.3748/wjg.v25.i47.6866. World J Gastroenterol. 2019. PMID: 31885427 Free PMC article.
-
Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.J Pediatr Gastroenterol Nutr. 2007 May;44(5):653-74. doi: 10.1097/MPG.0b013e31805563f3. J Pediatr Gastroenterol Nutr. 2007. PMID: 17460505
Cited by
-
Increasing Prevalence and Stable Incidence Rates of Inflammatory Bowel Disease Among First Nations: Population-Based Evidence From a Western Canadian Province.Inflamm Bowel Dis. 2022 Mar 30;28(4):514-522. doi: 10.1093/ibd/izab096. Inflamm Bowel Dis. 2022. PMID: 34037223 Free PMC article.
-
Comparison of outcomes of continuation/discontinuation of 5-aminosalicylic acid after initiation of anti-tumor necrosis factor-alpha therapy in patients with inflammatory bowel disease.Int J Colorectal Dis. 2019 Oct;34(10):1713-1721. doi: 10.1007/s00384-019-03368-1. Epub 2019 Aug 31. Int J Colorectal Dis. 2019. PMID: 31471699
-
Crohn's disease.Nat Rev Dis Primers. 2020 Apr 2;6(1):22. doi: 10.1038/s41572-020-0156-2. Nat Rev Dis Primers. 2020. PMID: 32242028 Review.
-
Diagnosis of inflammatory bowel disease-Asian perspectives: the results of a multinational web-based survey in the 8th Asian Organization for Crohn's and Colitis meeting.Intest Res. 2023 Jul;21(3):328-338. doi: 10.5217/ir.2023.00012. Epub 2023 Jul 27. Intest Res. 2023. PMID: 37533264 Free PMC article.
-
Lentinan-Based Oral Nanoparticle Loaded Budesonide With Macrophage-Targeting Ability for Treatment of Ulcerative Colitis.Front Bioeng Biotechnol. 2021 Aug 27;9:702173. doi: 10.3389/fbioe.2021.702173. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34513811 Free PMC article.
References
-
- Ng SC, Bernstein CN, Vatn MH, et al. Geographical variability and environmental risk factors in inflammatory bowel disease. Gut. 2013;62:630–649. - PubMed
-
- Chi KR. Epidemiology: rising in the east. Nature. 2016;540:S100–S102. - PubMed
-
- Ng SC, Shi HY, Hamidi N, et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies. Lancet. 2018;390:2769–2778. - PubMed
-
- Kaplan GG. The global burden of IBD: from 2015 to 2025. Nat Rev Gastroenterol Hepatol. 2015;12:720–727. - PubMed
LinkOut - more resources
Full Text Sources